PortalPublikationenDeletion of chromosome band 13q14 as detected by fluorescenc...

Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation.

Standard

Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation. / Kröger, Nicolaus-Martin; Schilling, Georgia; Einsele, Hermann; Liebisch, Peter; Shimoni, Avichai; Nagler, Arnon; Perez-Simon, Jose A; Miguel, San; Jesus, F; Kiehl, Michael; Fauser, Axel; Schwerdtfeger, Rainer; Wandt, Hannes; Sayer, Herbert G; Myint, Han; Zabelina, Tatjana; Zabelina, Tatjana; Dierlamm, Judith; Hinke, Axel; Zander, Axel.

in: BLOOD, Jahrgang 103, Nr. 11, 11, 2004, S. 4056-4061.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Kröger, N-M, Schilling, G, Einsele, H, Liebisch, P, Shimoni, A, Nagler, A, Perez-Simon, JA, Miguel, S, Jesus, F, Kiehl, M, Fauser, A, Schwerdtfeger, R, Wandt, H, Sayer, HG, Myint, H, Zabelina, T, Zabelina, T, Dierlamm, J, Hinke, A & Zander, A 2004, 'Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation.', BLOOD, Jg. 103, Nr. 11, 11, S. 4056-4061. <http://www.ncbi.nlm.nih.gov/pubmed/14982868?dopt=Citation>

APA

Kröger, N-M., Schilling, G., Einsele, H., Liebisch, P., Shimoni, A., Nagler, A., Perez-Simon, J. A., Miguel, S., Jesus, F., Kiehl, M., Fauser, A., Schwerdtfeger, R., Wandt, H., Sayer, H. G., Myint, H., Zabelina, T., Zabelina, T., Dierlamm, J., Hinke, A., & Zander, A. (2004). Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation. BLOOD, 103(11), 4056-4061. [11]. http://www.ncbi.nlm.nih.gov/pubmed/14982868?dopt=Citation

Vancouver

Kröger N-M, Schilling G, Einsele H, Liebisch P, Shimoni A, Nagler A et al. Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation. BLOOD. 2004;103(11):4056-4061. 11.

Bibtex

@article{9a78810bcd3549b2a67de5ab82613a70,
title = "Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation.",
abstract = "We investigated in a retrospective multicenter study the impact of chromosome arm 13q deletion (13q-) as detected by fluorescence in situ hybridization (FISH) on outcome after dose-reduced allografting in patients with multiple myeloma. In 68 of 140 patients, data on chromosome 13q status were available. Most patients included had advanced myeloma. At 2 years, patients with 13q deletion (n = 31) had a shorter event-free (18% vs 42%; P =.05) and overall survival (18% vs 67%; P =.03) than patients without 13q- (n = 37). Patients with 13q- experienced a higher relapse rate (77% vs 44%; P",
author = "Nicolaus-Martin Kr{\"o}ger and Georgia Schilling and Hermann Einsele and Peter Liebisch and Avichai Shimoni and Arnon Nagler and Perez-Simon, {Jose A} and San Miguel and F Jesus and Michael Kiehl and Axel Fauser and Rainer Schwerdtfeger and Hannes Wandt and Sayer, {Herbert G} and Han Myint and Tatjana Zabelina and Tatjana Zabelina and Judith Dierlamm and Axel Hinke and Axel Zander",
year = "2004",
language = "Deutsch",
volume = "103",
pages = "4056--4061",
journal = "BLOOD",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "11",

}

RIS

TY - JOUR

T1 - Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation.

AU - Kröger, Nicolaus-Martin

AU - Schilling, Georgia

AU - Einsele, Hermann

AU - Liebisch, Peter

AU - Shimoni, Avichai

AU - Nagler, Arnon

AU - Perez-Simon, Jose A

AU - Miguel, San

AU - Jesus, F

AU - Kiehl, Michael

AU - Fauser, Axel

AU - Schwerdtfeger, Rainer

AU - Wandt, Hannes

AU - Sayer, Herbert G

AU - Myint, Han

AU - Zabelina, Tatjana

AU - Zabelina, Tatjana

AU - Dierlamm, Judith

AU - Hinke, Axel

AU - Zander, Axel

PY - 2004

Y1 - 2004

N2 - We investigated in a retrospective multicenter study the impact of chromosome arm 13q deletion (13q-) as detected by fluorescence in situ hybridization (FISH) on outcome after dose-reduced allografting in patients with multiple myeloma. In 68 of 140 patients, data on chromosome 13q status were available. Most patients included had advanced myeloma. At 2 years, patients with 13q deletion (n = 31) had a shorter event-free (18% vs 42%; P =.05) and overall survival (18% vs 67%; P =.03) than patients without 13q- (n = 37). Patients with 13q- experienced a higher relapse rate (77% vs 44%; P

AB - We investigated in a retrospective multicenter study the impact of chromosome arm 13q deletion (13q-) as detected by fluorescence in situ hybridization (FISH) on outcome after dose-reduced allografting in patients with multiple myeloma. In 68 of 140 patients, data on chromosome 13q status were available. Most patients included had advanced myeloma. At 2 years, patients with 13q deletion (n = 31) had a shorter event-free (18% vs 42%; P =.05) and overall survival (18% vs 67%; P =.03) than patients without 13q- (n = 37). Patients with 13q- experienced a higher relapse rate (77% vs 44%; P

M3 - SCORING: Zeitschriftenaufsatz

VL - 103

SP - 4056

EP - 4061

JO - BLOOD

JF - BLOOD

SN - 0006-4971

IS - 11

M1 - 11

ER -